GENESIS Biomed Revenue and Competitors
Estimated Revenue & Valuation
- GENESIS Biomed's estimated annual revenue is currently $3.4M per year.
- GENESIS Biomed's estimated revenue per employee is $155,000
Employee Data
- GENESIS Biomed has 22 Employees.
- GENESIS Biomed grew their employee count by 5% last year.
GENESIS Biomed's People
Name | Title | Email/Phone |
---|
GENESIS Biomed Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.4M | 41 | N/A | N/A | N/A |
#2 | $0.9M | 6 | N/A | N/A | N/A |
#3 | $5.9M | 38 | N/A | N/A | N/A |
#4 | $47M | 303 | 18% | N/A | N/A |
#5 | $9.5M | 61 | 11% | N/A | N/A |
#6 | $46.7M | 301 | 25% | N/A | N/A |
#7 | $1.7M | 11 | -8% | N/A | N/A |
#8 | $3.7M | 24 | -11% | N/A | N/A |
#9 | $4.2M | 27 | 13% | N/A | N/A |
#10 | $5.3M | 34 | 6% | N/A | N/A |
What Is GENESIS Biomed?
GENESIS Biomed is a consulting company formed by entrepreneurs and with vocation of service to entrepreneurs and research centers. In GENESIS Biomed we offer consulting services, we invest in projects in seed stage and we develop our own R+D projects. Our sectors are biopharmaceutical, biotechnological, medical devices, in vitro diagnostic, foodtech, nutraceutical and cosmetic. We are born in May 2017 and we are located in the Barcelona Science Park.
keywords:N/AN/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
GENESIS Biomed News
Darrin Benjumea is an employee of Genesis Research who has been contracted by ... Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/217047.
Las consultoras Genesis Biomed y FI Group, consultoras estratégicas y biomédicas han creado Genesis Tech Transfer Boost, han creado un...
... Harbour Biomed, Sinclair Bio Resources, Alpha Genesis Inc., Creative Animodel, DaVinci Biomedical Research Products, Inc.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 22 | -4% | N/A |
#2 | $2.2M | 22 | -15% | N/A |
#3 | N/A | 22 | 5% | N/A |
#4 | N/A | 22 | -21% | N/A |
#5 | $2.3M | 23 | -28% | N/A |